机译:吉西他滨肝动脉化疗方案治疗无法切除的胆管癌和胰腺癌肝转移的临床研究:最大耐受剂量和治疗效果的临床研究
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Department of Oncology Heilbrunn Oncological Clinic Heilbrunn Leonardis Clinic Abt-Walther-Weg 15-16 83670 Bad Heilbrunn Germany;
Department of Oncology Heilbrunn Oncological Clinic Heilbrunn Leonardis Clinic Abt-Walther-Weg 15-16 83670 Bad Heilbrunn Germany;
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Institute for Diagnostic and Interventional Radiology Johann Wolfgang Goethe-University Clinic Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany;
Liver metastases; Intraarterial chemotherapy; Gemcitabine; Cholangiocarcinomas;
机译:吉西他滨对不可切除的胆管癌和胰腺癌肝转移患者的肝动脉化疗:最大耐受剂量和治疗效果的临床研究。
机译:肝动脉输液化疗的治疗肝脏肝脏输液化疗患者肝脏直肠转移患者仍然不可切除,后系统诱导化疗后仍然不可切除 - 一种随机期II研究 - 苏丹UCGI 30 / PRODIGE 53(NCT03164655) - 研究方案 - 研究方案
机译:肝脏动脉输液化疗5氟尿嘧啶,对结直肠癌难以切除的肝脏转移患者标准全身化疗:多中心回顾性研究
机译:超声微泡靶向吉西他滨递送治疗胰腺癌
机译:吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
机译:吉西他滨和5-氟尿嘧啶肝动脉灌注化疗对胰腺癌术后肝转移患者的初步研究
机译:具有吉西他滨和5-氟尿嘧啶或口服S-1的肝动脉输注化疗改善了胰腺癌术后肝转移患者的预后